Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

BACKGROUND: There is limited evidence on the clinical and economic benefit of achieving disease control in psoriatic arthritis (PsA) and ankylosing spondylitis (AS), thus we aimed to assess the impact of disease control on healthcare resource use (HCRU) and direct medical costs among US patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergman, Martin J., Zueger, Patrick, Patel, Jayeshkumar, Saffore, Christopher D., Topuria, Ia, Cavanaugh, Cristi, Fang, Siran, Clewell, Jerry, Ogdie, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931970/
https://www.ncbi.nlm.nih.gov/pubmed/36333490
http://dx.doi.org/10.1007/s40744-022-00504-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931970/
https://www.ncbi.nlm.nih.gov/pubmed/36333490
http://dx.doi.org/10.1007/s40744-022-00504-2

Ejemplares similares